Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases”

Detalles Bibliográficos
Autor principal: Talotta, Rossella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833091/
https://www.ncbi.nlm.nih.gov/pubmed/33429060
http://dx.doi.org/10.1016/j.clim.2021.108665

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833091/
https://www.ncbi.nlm.nih.gov/pubmed/33429060
http://dx.doi.org/10.1016/j.clim.2021.108665

Ejemplares similares